NUE

NUE Change in Working Capital

-$661.00MTTM · USD

Period ending:

NUE FY Change in Working CapitalUSD
NUE FY Change in Working Capital1989-12-31: -$48.10M1990-12-31: $17.60M1991-12-31: -$7.00M1992-12-31: $8.20M1993-12-31: $15.30M1994-12-31: $24.90M1995-12-31: -$61.30M1996-12-31: -$54.30M1997-12-31: -$69.30M1998-12-31: $23.70M1999-12-31: $7.40M2000-12-31: $77.81M2001-12-31: -$724.39K2002-12-31: -$122.35M2003-12-31: -$5.14M2004-12-31: -$599.40M2005-12-31: $313.74M2006-12-31: -$83.99M2007-12-31: -$202.47M2008-12-31: -$93.59M2009-12-31: $615.60M2010-12-31: -$135.52M2011-12-31: -$551.37M2012-12-31: -$86.11M2013-12-31: -$235.21M2014-12-31: -$342.90M2015-12-31: $1.22B2016-12-31: $32.72M2017-12-31: -$902.93M2018-12-31: -$983.16M2019-12-31: $413.27M2020-12-31: $204.00M2021-12-31: -$1.86B2022-12-30: $693.00M2023-12-31: $858.00M2024-12-31: $156.00M2025-12-31: -$636.00M$1.22B-$1.86B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NUE change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Nucor Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-636,000,000
156,000,000
858,000,000
693,000,000
-1,862,890,000
204,000,000
413,270,000
-983,164,000
-902,931,000
32,720,000
1,222,120,000
-342,900,000
-235,213,000
-86,107,000
-551,371,000
-135,516,000
615,597,000
-93,590,000
-202,471,000
-83,994,000
313,741,000
-599,400,000
-5,139,038
-122,347,744
-724,388
77,806,068
7,400,000
23,700,000
-69,300,000
-54,300,000
-61,300,000
24,900,000
15,300,000
8,200,000
-7,000,000
17,600,000
-48,100,000

Compare change in working capital

All NUE financial metrics · NUE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.